| Year |
Citation |
Score |
| 2024 |
Marano M, Pilotto A, Padovani A, Gupta D, Vivacqua G, Magliozzi A, Di Lazzaro V, Carta M, Meloni M. The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease. Journal of Neurology. PMID 38720139 DOI: 10.1007/s00415-024-12400-6 |
0.329 |
|
| 2023 |
Corsi S, Scheggi S, Pardu A, Braccagni G, Caruso D, Cioffi L, Diviccaro S, Gentile M, Fanni S, Stancampiano R, Gambarana C, Melcangi RC, Frau R, Carta M. Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370]. Experimental Neurology. 114640. PMID 38104017 DOI: 10.1016/j.expneurol.2023.114640 |
0.379 |
|
| 2023 |
Serra M, Di Maio A, Bassareo V, Nuzzo T, Errico F, Servillo F, Capasso M, Parekh P, Li Q, Thiolat ML, Bezard E, Calabresi P, Sulzer D, Carta M, Morelli M, et al. Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 106226. PMID 37451474 DOI: 10.1016/j.nbd.2023.106226 |
0.423 |
|
| 2023 |
Di Maio A, Nuzzo T, Gilio L, Serra M, Buttari F, Errico F, De Rosa A, Bassi MS, Morelli M, Sasabe J, Sulzer D, Carta M, Centonze D, Usiello A. Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients. Neurobiology of Disease. 106203. PMID 37336364 DOI: 10.1016/j.nbd.2023.106203 |
0.316 |
|
| 2021 |
Corsi S, Stancampiano R, Carta M. Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update. Progress in Brain Research. 261: 287-302. PMID 33785132 DOI: 10.1016/bs.pbr.2021.01.032 |
0.494 |
|
| 2020 |
Scheggi S, Rossi F, Corsi S, Fanni S, Tronci E, Ludovica C, Vargiu R, Gambarana C, Muñoz A, Stancampiano R, Bjorklund A, Carta M. BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease. PMID 32651332 DOI: 10.3233/Jpd-202061 |
0.727 |
|
| 2020 |
Meloni M, Puligheddu M, Sanna F, Cannas A, Farris R, Tronci E, Figorilli M, Defazio G, Carta M. Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869. PMID 32464351 DOI: 10.1016/J.Jns.2020.116869 |
0.663 |
|
| 2020 |
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjo J, Hjorth S, Waters N. Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. PMID 32358046 DOI: 10.1124/Jpet.119.264226 |
0.501 |
|
| 2020 |
Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G. Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding. European Journal of Neurology. PMID 32067288 DOI: 10.1111/Ene.14179 |
0.379 |
|
| 2020 |
Corsi S, Scheggi S, Rossi F, Fanni S, Tronci E, Congiu L, Vargiu R, Gambarana C, Muñoz A, Stancampiano R, Bjorklund A, Carta M. P.208 BDNF overexpression exacerbates D1R agonist-induced dyskinesia in hemiparkinsonian rats via D1R-D3R heteromers formation European Neuropsychopharmacology. 31. DOI: 10.1016/J.Euroneuro.2019.12.034 |
0.359 |
|
| 2019 |
Cocco C, Corda G, Lisci C, Noli B, Carta M, Brancia C, Manca E, Masala C, Marrosu F, Solla P, Manconi B, Bongioanni P, Ferri GL. VGF peptides as novel biomarkers in Parkinson's disease. Cell and Tissue Research. PMID 31713727 DOI: 10.1007/S00441-019-03128-1 |
0.405 |
|
| 2019 |
Nuzzo T, Punzo D, Devoto P, Rosini E, Paciotti S, Sacchi S, Li Q, Thiolat ML, Véga C, Carella M, Carta M, Gardoni F, Calabresi P, Pollegioni L, Bezard E, et al. The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients. Scientific Reports. 9: 8898. PMID 31222058 DOI: 10.1038/S41598-019-45419-1 |
0.466 |
|
| 2018 |
Fanni S, Scheggi S, Rossi F, Tronci E, Traccis F, Stancampiano R, De Montis MG, Devoto P, Gambarana C, Bortolato M, Frau R, Carta M. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130. PMID 30261284 DOI: 10.1016/J.Nbd.2018.09.018 |
0.743 |
|
| 2018 |
Carta M, Hirsch E. Dyskinesia in Parkinson's disease: a clinical complication and an open scientific question. Journal of Neural Transmission (Vienna, Austria : 1996). 125: 1107. PMID 30014356 DOI: 10.1007/S00702-018-1907-Z |
0.34 |
|
| 2018 |
Carta M, Björklund A. The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29480391 DOI: 10.1007/S00702-018-1865-5 |
0.509 |
|
| 2017 |
Tronci E, Napolitano F, Muñoz A, Fidalgo C, Rossi F, Björklund A, Usiello A, Carta M. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology. PMID 28757258 DOI: 10.1016/J.Expneurol.2017.07.017 |
0.724 |
|
| 2017 |
D Ko WK, Li Q, Yun Cheng L, Morelli M, Carta M, Bezard E. A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease. European Journal of Pharmacology. PMID 28739086 DOI: 10.1016/J.Ejphar.2017.07.030 |
0.523 |
|
| 2017 |
Frau R, Savoia P, Fanni S, Fiorentini C, Fidalgo C, Tronci E, Stancampiano R, Meloni M, Cannas A, Marrosu F, Bortolato M, Devoto P, Missale C, Carta M. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology. PMID 28131725 DOI: 10.1016/J.Expneurol.2017.01.012 |
0.726 |
|
| 2016 |
Pinna A, Ko WK, Costa G, Tronci E, Fidalgo C, Simola N, Li Q, Tabrizi MA, Bezard E, Carta M, Morelli M. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26871939 DOI: 10.1002/Mds.26475 |
0.706 |
|
| 2016 |
Carta M, Cenci MA. On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 149. PMID 26749366 DOI: 10.1002/Mds.26519 |
0.323 |
|
| 2016 |
Ghiglieri V, Mineo D, Vannelli A, Cacace F, Mancini M, Pendolino V, Napolitano F, di Maio A, Mellone M, Stanic J, Tronci E, Fidalgo C, Stancampiano R, Carta M, Calabresi P, et al. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. Neurobiology of Disease. 86: 140-53. PMID 26639853 DOI: 10.1016/J.Nbd.2015.11.022 |
0.74 |
|
| 2016 |
Fanni S, Frau R, Tronci E, Fidalgo C, Lisci C, Pardu A, Pes R, Saba P, Devoto P, Bortolato M, Carta M. P.2.018 Role of 5-alpha reductase in the pathophysiology of L-DOPA induced dyskinesia European Neuropsychopharmacology. 26: S38-S39. DOI: 10.1016/S0924-977X(16)70044-7 |
0.64 |
|
| 2015 |
Tronci E, Fidalgo C, Carta M. Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia. Parkinson's Disease. 2015: 563820. PMID 26881178 DOI: 10.1155/2015/563820 |
0.712 |
|
| 2015 |
Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, ... ... Carta M, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002 |
0.701 |
|
| 2015 |
Tronci E, Fidalgo C, Stancampiano R, Carta M. Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats. Behavioural Brain Research. 292: 300-304. PMID 26119238 DOI: 10.1016/J.Bbr.2015.06.034 |
0.741 |
|
| 2015 |
Fidalgo C, Ko WK, Tronci E, Li Q, Stancampiano R, Chuan Q, Bezard E, Carta M. Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Neuroscience. 298: 389-96. PMID 25907446 DOI: 10.1016/J.Neuroscience.2015.04.027 |
0.724 |
|
| 2015 |
Bezard E, Carta M. Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease? Brain : a Journal of Neurology. 138: 829-30. PMID 25669729 DOI: 10.1093/Brain/Awu407 |
0.333 |
|
| 2015 |
Tronci E, Fidalgo C, Carta M. Foetal cell transplantation for Parkinson's disease: Focus on graft-induced dyskinesia Parkinson's Disease. 2015. DOI: 10.1155/2015/563820 |
0.6 |
|
| 2014 |
Carta M, Tronci E. Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. Frontiers in Neurology. 5: 78. PMID 24904522 DOI: 10.3389/Fneur.2014.00078 |
0.75 |
|
| 2014 |
Shin E, Rogers JT, Devoto P, Björklund A, Carta M. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Experimental Neurology. 257: 25-38. PMID 24747357 DOI: 10.1016/J.Expneurol.2014.04.011 |
0.703 |
|
| 2014 |
Tronci E, Fidalgo C, Zianni E, Collu M, Stancampiano R, Morelli M, Gardoni F, Carta M. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. Neuroscience. 265: 245-52. PMID 24486947 DOI: 10.1016/J.Neuroscience.2014.01.042 |
0.735 |
|
| 2014 |
Shin E, Lisci C, Tronci E, Fidalgo C, Stancampiano R, Björklund A, Carta M. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of Disease. 62: 233-40. PMID 24135006 DOI: 10.1016/J.Nbd.2013.09.021 |
0.784 |
|
| 2014 |
Cocco C, Angioni L, Bongioanni P, Carta M, D’Amato F, Lisci C, Ferri G. Vgf Involvement On Parkinson’S Disease Italian Journal of Anatomy and Embryology. 119: 47. DOI: 10.13128/Ijae-15878 |
0.425 |
|
| 2014 |
Tronci E, Fidalgo C, Carta M. The serotonergic system in levodopa-induced dyskinesia Levodopa-Induced Dyskinesia in Parkinson's Disease. 199-212. DOI: 10.1007/978-1-4471-6503-3_11 |
0.649 |
|
| 2013 |
Bézard E, Muñoz A, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neuroscience Research. 77: 242-6. PMID 24135129 DOI: 10.1016/J.Neures.2013.10.002 |
0.782 |
|
| 2013 |
Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model. Neurobiology of Disease. 60: 108-14. PMID 24004632 DOI: 10.1016/J.Nbd.2013.08.014 |
0.764 |
|
| 2013 |
Bezard E, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1088-96. PMID 23389842 DOI: 10.1002/Mds.25366 |
0.772 |
|
| 2013 |
Stancampiano R, Frau R, Bini V, Collu M, Carta M, Fadda F, Bortolato M. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HTâ‚‚ receptor activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1329-35. PMID 23141373 DOI: 10.1016/J.Euroneuro.2012.10.009 |
0.377 |
|
| 2013 |
Tronci E, Carta M. 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation Basal Ganglia. 3: 9-13. DOI: 10.1016/J.Baga.2012.12.002 |
0.746 |
|
| 2012 |
Shin E, Tronci E, Carta M. Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease. Parkinson's Disease. 2012: 370190. PMID 22762012 DOI: 10.1155/2012/370190 |
0.821 |
|
| 2012 |
Shin E, Garcia J, Winkler C, Björklund A, Carta M. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiology of Disease. 47: 393-406. PMID 22579773 DOI: 10.1016/J.Nbd.2012.03.038 |
0.718 |
|
| 2012 |
Tronci E, Shin E, Björklund A, Carta M. Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study. Neuroscience Research. 73: 168-72. PMID 22450171 DOI: 10.1016/J.Neures.2012.03.004 |
0.763 |
|
| 2011 |
Navailles S, Carta M, Guthrie M, De Deurwaerdère P. L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease. Central Nervous System Agents in Medicinal Chemistry. 11: 305-20. PMID 22117594 DOI: 10.2174/1871524911106040305 |
0.565 |
|
| 2011 |
Errico F, Bonito-Oliva A, Bagetta V, Vitucci D, Romano R, Zianni E, Napolitano F, Marinucci S, Di Luca M, Calabresi P, Fisone G, Carta M, Picconi B, Gardoni F, Usiello A. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Experimental Neurology. 232: 240-50. PMID 21946266 DOI: 10.1016/J.Expneurol.2011.09.013 |
0.473 |
|
| 2011 |
Carta M, Bezard E. Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia. Neuroscience. 198: 245-51. PMID 21840375 DOI: 10.1016/J.Neuroscience.2011.07.070 |
0.536 |
|
| 2010 |
Morizane A, Darsalia V, Guloglu MO, Hjalt T, Carta M, Li JY, Brundin P. A simple method for large-scale generation of dopamine neurons from human embryonic stem cells. Journal of Neuroscience Research. 88: 3467-78. PMID 20981866 DOI: 10.1002/Jnr.22515 |
0.578 |
|
| 2010 |
Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11043-56. PMID 20720111 DOI: 10.1523/Jneurosci.1682-10.2010 |
0.448 |
|
| 2010 |
Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S174-9. PMID 20187238 DOI: 10.1002/Mds.22792 |
0.771 |
|
| 2010 |
Björklund T, Carlsson T, Cederfjäll EA, Carta M, Kirik D. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease. Brain : a Journal of Neurology. 133: 496-511. PMID 20129936 DOI: 10.1093/Brain/Awp314 |
0.735 |
|
| 2009 |
Kadkhodaei B, Ito T, Joodmardi E, Mattsson B, Rouillard C, Carta M, Muramatsu S, Sumi-Ichinose C, Nomura T, Metzger D, Chambon P, Lindqvist E, Larsson NG, Olson L, Björklund A, et al. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15923-32. PMID 20016108 DOI: 10.1523/Jneurosci.3910-09.2009 |
0.434 |
|
| 2009 |
Björklund T, Hall H, Breysse N, Soneson C, Carlsson T, Mandel RJ, Carta M, Kirik D. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats. Journal of Neurochemistry. 111: 355-67. PMID 19686242 DOI: 10.1111/J.1471-4159.2009.06340.X |
0.773 |
|
| 2009 |
Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Experimental Neurology. 219: 298-307. PMID 19500572 DOI: 10.1016/J.Expneurol.2009.05.033 |
0.808 |
|
| 2009 |
Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain : a Journal of Neurology. 132: 319-35. PMID 19039008 DOI: 10.1093/Brain/Awn305 |
0.793 |
|
| 2008 |
Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain : a Journal of Neurology. 131: 3380-94. PMID 18952677 DOI: 10.1093/Brain/Awn235 |
0.776 |
|
| 2008 |
Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Progress in Brain Research. 172: 465-78. PMID 18772046 DOI: 10.1016/S0079-6123(08)00922-9 |
0.777 |
|
| 2008 |
Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Involvement of the serotonin system in L-dopa-induced dyskinesias. Parkinsonism & Related Disorders. 14: S154-8. PMID 18579429 DOI: 10.1016/J.Parkreldis.2008.04.021 |
0.789 |
|
| 2008 |
Bortolato M, Frau R, Orrù M, Collu M, Mereu G, Carta M, Fadda F, Stancampiano R. Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats. Psychopharmacology. 198: 191-200. PMID 18330544 DOI: 10.1007/S00213-008-1116-9 |
0.481 |
|
| 2008 |
Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007 |
0.432 |
|
| 2007 |
Carlsson T, Carta M, Winkler C, Björklund A, Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8011-22. PMID 17652591 DOI: 10.1523/Jneurosci.2079-07.2007 |
0.81 |
|
| 2007 |
Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Hervé D, Greengard P, Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6995-7005. PMID 17596448 DOI: 10.1523/Jneurosci.0852-07.2007 |
0.376 |
|
| 2007 |
Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain : a Journal of Neurology. 130: 1819-33. PMID 17452372 DOI: 10.1093/Brain/Awm082 |
0.803 |
|
| 2006 |
Maingay M, Romero-Ramos M, Carta M, Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiology of Disease. 23: 522-32. PMID 16806952 DOI: 10.1016/J.Nbd.2006.04.007 |
0.761 |
|
| 2006 |
Carta M, Fadda F, Stancampiano R. Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine. Brain Research. 1094: 86-91. PMID 16729986 DOI: 10.1016/J.Brainres.2006.03.118 |
0.377 |
|
| 2006 |
Carta M, Collu M, Fadda F, Stancampiano R. Augmented cocaine-induced accumbal dopamine efflux, motor activity and place preference in rats fed with a tryptophan-deficient diet. Neuroscience Letters. 401: 125-9. PMID 16581186 DOI: 10.1016/J.Neulet.2006.03.002 |
0.379 |
|
| 2006 |
Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U, Carta M, Hanse E, Takahashi J, Sasai Y, Funa K, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (Dayton, Ohio). 24: 1433-40. PMID 16556709 DOI: 10.1634/Stemcells.2005-0393 |
0.612 |
|
| 2006 |
Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. Journal of Neurochemistry. 96: 1718-27. PMID 16539687 DOI: 10.1111/J.1471-4159.2006.03696.X |
0.541 |
|
| 2006 |
Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience. 139: 1163-72. PMID 16530976 DOI: 10.1016/J.Neuroscience.2006.01.027 |
0.665 |
|
| 2006 |
Borgkvist A, Puelles E, Carta M, Acampora D, Ang SL, Wurst W, Goiny M, Fisone G, Simeone A, Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neurosciences. 31: 293-302. PMID 16256364 DOI: 10.1016/J.Mcn.2005.09.018 |
0.419 |
|
| 2005 |
Lundblad M, Usiello A, Carta M, HÃ¥kansson K, Fisone G, Cenci MA. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Experimental Neurology. 194: 66-75. PMID 15899244 DOI: 10.1016/J.Expneurol.2005.02.002 |
0.546 |
|
| 2004 |
Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiology of Disease. 17: 219-36. PMID 15474360 DOI: 10.1016/J.Nbd.2004.07.005 |
0.482 |
|
| Show low-probability matches. |